vimarsana.com

Latest Breaking News On - Hedge funds weigh in on amneal pharmaceuticals - Page 2 : vimarsana.com

Amneal Pharmaceuticals (NYSE:AMRX) Sets New 12-Month High at $5 85

Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The stock traded as high as $5.85 and last traded at $5.78, with a volume of 84835 shares changing hands. The stock had previously closed at $5.76. Wall Street Analysts Forecast Growth AMRX has been the topic […]

Amneal Pharmaceuticals (NYSE:AMRX) Trading Down 7 4%

Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report) shares traded down 7.4% during trading on Wednesday . The company traded as low as $3.97 and last traded at $4.02. 437,237 shares were traded during trading, a decline of 59% from the average session volume of 1,064,612 shares. The stock had previously closed at $4.34. Wall […]

Amneal Pharmaceuticals (NYSE:AMRX) PT Raised to $5 00

Amneal Pharmaceuticals (NYSE:AMRX – Free Report) had its price target raised by Piper Sandler from $3.00 to $5.00 in a research note published on Monday, MarketBeat Ratings reports. Piper Sandler currently has an overweight rating on the stock. AMRX has been the subject of a number of other reports. Barclays boosted their target price on […]

Amneal Pharmaceuticals (NYSE:AMRX) Given New $5 00 Price Target at Barclays

Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) had its price objective lifted by investment analysts at Barclays from $4.00 to $5.00 in a research report issued on Friday, FlyOnTheWall reports. Barclays‘s price objective suggests a potential upside of 21.65% from the stock’s current price. Other research analysts also recently issued reports about the company. Piper […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.